This report discusses the benefits and negatives of decentralised clinical trials and how we have seen increased growth in them specifically since the pandemic. It also raises the question of whether they will become more prominent in the future and what concerns the industry needs to address to ensure that they have the best possible success.
The report discusses the following points in further detail:
- The benefits that decentralised clinical trials hold and what advantages they can bring that conventional trials do not
- The issues and limitations surrounding decentralised clinical trials and how this can be mitigated
- Key takeaways from the 2023 HealthTechX Summit on Decentralised Clinical Trials that some of the team recently attended
- An overall conclusion on how decentralised trials have the potential to revolutionise the clinical trial process
To find out more, read the full report here: CLS Insights – Decentralised Clinical Trials
For all the latest news from Compass Life Sciences, click here.